Synonyms: Enbrel® | Rhu Tnfr:Fc | TNFR-Fc | TNR 001
etanercept is an approved drug (FDA (1998), EMA (2000))
Compound class:
Peptide
Comment: Etanercept is a TNFα inhibitor. It is a dimeric recombinant protein fusing the TNF receptor 2 (TNFRSF1B) to the Fc region of the human IgG1 antibody. Etanercept is used as a disease-modifying anti-rheumatic drug (DMARD).
Biosimilars:
View more information in the IUPHAR Pharmacology Education Project: etanercept |
Classification | |
Compound class | Peptide |
Approved drug? | Yes (FDA (1998), EMA (2000)) |
International Nonproprietary Names | |
INN number | INN |
7783 | etanercept |
Synonyms |
Enbrel® | Rhu Tnfr:Fc | TNFR-Fc | TNR 001 |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 216 |
Other databases | |
CAS Registry No. | 185243-69-0 |
ChEMBL Ligand | CHEMBL1201572 |
DrugBank Ligand | DB00005 |
GtoPdb PubChem SID | 178103395 |
PubChem SID | 135343504 |
Search PubMed clinical trials | etanercept |
Search PubMed titles | etanercept |
Search PubMed titles/abstracts | etanercept |
Wikipedia | Etanercept |